EASL Liver Cancer Summit 2025

Location: Paris, France

Date:

Event description:

Novotech will attend the EASL Liver Cancer Summit 2025, a key event focused on advancements in liver cancer research and treatment. Discussions will cover recent progress in primary liver cancer, with a focus on hepatocellular carcinoma and cholangiocarcinoma, as well as innovations in immunotherapy, systemic therapies, and artificial intelligence-driven diagnostics. 

As a specialized contract research organization (CRO), Novotech provides: 

  • Strong investigator networks to quickly identify optimal trial sites for liver disease studies
  • 25 years of experience delivering high-quality CRO services for biotechnology companies
  • A biotech-focused approach tailored to support liver disease clinical research 

Meet Lotfi Rachedi, Regional Director, Business Development 

Lotfi Rachedi will be available to discuss Novotech’s expertise in liver disease clinical trials and how its tailored approach can support biotechnology companies. 

Schedule a meeting via the MyEASL app

This event has concluded

Thank you for your interest in Novotech at this event. While the event has ended, our experts continue to support sponsors across all stages of clinical development.

Have a question or want to continue the conversation?

Talk to a Clinical Development Expert

Meet Our Team

Novotech

Lotfi Rachedi

Novotech
Regional Director Business Development

Plus experts from our China, Drug Development, and global Commercial teams.